HealthcareServices

Hemoglobin A1c (HbA1c) Testing Market 2026–2030: Forecasting Business Opportunities Ahead

February 25, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the hemoglobin a1c (hba1c) testing market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Hemoglobin A1c (HbA1c) Testing Market from 2026 to 2030?

The hemoglobin a1c (hba1c) testing market size has experienced rapid expansion in recent years. It is forecast to increase from $2.02 billion in 2025 to $2.24 billion in 2026, at a compound annual growth rate (CAGR) of 10.5%. This growth observed in the past can be attributed to the rising global incidence of diabetes, the increased application of long-term glucose monitoring, the expansion of diagnostic laboratory facilities, growing public awareness of diabetes screening, and the wider acceptance of hba1c as a diagnostic benchmark.

The hemoglobin a1c (hba1c) testing market size is anticipated to experience significant expansion over the upcoming years. This market is projected to reach $3.31 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.3%. This projected growth is primarily attributable to factors such as the increasing acceptance of home-based diabetes monitoring, a surge in investments towards connected diagnostic devices, the broadening of preventive healthcare programs, a heightened emphasis on the early detection of diabetes, and the escalating need for quick diagnostic solutions. Key trends anticipated during this period encompass the greater uptake of point-of-care hba1c testing devices, a heightened demand for portable and home-use hba1c analyzers, the expanding incorporation of wireless and connected testing solutions, the advancement of high-accuracy laboratory-based hba1c technologies, and a stronger emphasis on both standardization and diagnostic accuracy.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18632&type=smp

What Drivers Are Affecting Demand In The Hemoglobin A1c (HbA1c) Testing Market?

The rising occurrence of diabetes is anticipated to fuel the expansion of the hemoglobin A1c (HbA1c) testing market in the future. Diabetes, a long-term health issue, involves the body’s inability to adequately control blood glucose levels, stemming from either inadequate insulin production or insulin resistance. Cases of diabetes are increasing, largely attributable to unhealthy eating habits, particularly a significant intake of processed foods and sweetened beverages, alongside inactive lifestyles marked by limited physical movement. Furthermore, an aging demographic and a familial predisposition to diabetes elevate the likelihood of developing the condition. HbA1c testing serves to track blood glucose management over an extended period in individuals with diabetes, assessing the average blood sugar concentration from the preceding 2–3 months. For example, data released in June 2023 by The Lancet, a UK-based publisher of books and periodic data, indicates that worldwide diabetes cases are forecast to rise from 529 million in 2021 to 1.3 billion by 2050. Consequently, the growing incidence of diabetes is set to stimulate the expansion of the hemoglobin A1c (HbA1c) testing market.

Which Segments Are Gaining Traction In The Hemoglobin A1c (HbA1c) Testing Market?

The hemoglobin a1c (hba1c) testing market covered in this report is segmented –

1) By Testing Method: Laboratory-Based Testing, Point Of Care (PoC) Testing

2) By Product Type: Instruments, Reagents, Kits

3) By Technology: Immunoassays, Chromatography, Enzymatic Assays, Boronate Affinity Chromatography, High Performance Liquid Chromatography

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Homecare Settings

Subsegments:

1) By Laboratory-Based Testing: High-Performance Liquid Chromatography (HPLC) Testing, Ion-Exchange Chromatography, Capillary Electrophoresis

2) By Point Of Care (PoC) Testing: Fingerstick Testing Devices, Portable Hba1c Analyzers, Handheld Hba1c Test Kits

Which Competitive Trends Are Impacting The Structure Of The Hemoglobin A1c (HbA1c) Testing Market?

Major companies operating in the Hemoglobin A1c (HbA1c) testing market are emphasizing technological advancements in diagnostic testing, such as HbA1c home tests, to deliver more convenient, accurate, and accessible options for early diabetes detection and management. HbA1c home tests are defined as at-home diagnostic kits that enable individuals to measure their average blood sugar levels over the past 2-3 months, thereby aiding in diabetes monitoring and management. For instance, in February 2023, Hurdle Health, a US-based company focused on providing innovative healthcare solutions, including diagnostic tools for chronic disease management, launched its Hemoglobin A1c (HbA1c) Test. This new at-home blood sample test allows adults to screen for and monitor diabetes, furthering Chronomics’ mission to enhance accessibility to diagnostic testing and improve health outcomes through direct-to-consumer solutions.

Who Are The Prominent Global Companies Shaping The Hemoglobin A1c (HbA1c) Testing Market Landscape?

Major companies operating in the hemoglobin a1c (hba1c) testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Tosoh Corporation, Hitachi High-Technologies Corporation, Beckman Coulter Inc, Sysmex Corporation, Bio Rad Laboratories Inc, ARKRAY Inc, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Agappe Diagnostics Ltd, SEKISUI Diagnostics LLC, Helena Laboratories, Transasia Bio Medicals Ltd, EKF Diagnostics, Trinity Biotech plc, HemoCue AB, CPC Diagnostics Pvt Ltd, PTS Diagnostics, Menarini Diagnostics srl, Diazyme Laboratories Inc, Osang HealthCare Co Ltd, Eurolyser Diagnostica GmbH, DiaSys Diagnostic Systems GmbH

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report

Which Region Is Projected To Lead The Hemoglobin A1c (HbA1c) Testing Market During The Forecast Period?

North America was the largest region in the hemoglobin A1c (HbA1c) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobin a1c (hba1c) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hemoglobin A1c (HbA1c) Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18632&type=smp

Browse Through More Reports Similar to the Global Hemoglobin A1c (HbA1c) Testing Market 2026, By The Business Research Company

Poc Hba1C Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/poc-hba1c-testing-global-market-report

Hemoglobin A1C Testing Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-testing-devices-global-market-report

Hemoglobin Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795